Sclerostin-neutralizing antibody inhibited periarticular and systemic bone loss in the mouse models of RA [46], whereas genetic Sost (encoding sclerostin) deletion aggravated joint inflammation and destruction in TNF transgenic mice because sclerostin blocks signaling pathways downstream of TNF [45]. Here, SOST is linked to rheumatoid arthritis.